Европейский рынок офтальмологии – тенденции отрасли и прогноз до 2030 года

Настройте свой отчет Настройте свой отчет Купить сейчас Купить сейчас Бесплатный пример отчета Бесплатный пример отчета
Дом Medical Devices Europe Ophthalmology Market
Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Европейский рынок офтальмологии – тенденции отрасли и прогноз до 2030 года

  • Medical Devices
  • Published Report
  • Jan 2023
  • Europe
  • 350 Pages
  • Количество таблиц: 571
  • Количество рисунков: 47
Купить сейчасКупить сейчас

Europe Ophthalmology Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
 2023 –2030
Diagram Размер рынка (базовый год)
 USD 14,789.41 Million
Diagram Размер рынка (прогнозируемый год)
 USD 23,186.51 Million
Diagram CAGR
 %
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Запрос на разблокировку

>Европейский рынок офтальмологии, по видам продукции (устройства, лекарства и другие), заболевания (глаукома, катаракта, возрастная макулярная дегенерация, воспалительные заболевания, нарушения рефракции и другие), режим отпуска по рецепту (дженерики и брендовые), тип препарата (рецептурные и безрецептурные), способ применения (пероральный, местный, инъекционные, местно-офтальмологические и другие), конечный пользователь (больницы, клиники, домашняя медицинская помощь и другие), канал сбыта (прямые торги, розничные продажи и другие) — тенденции отрасли и прогноз до 2030 года.

Европейский рынок офтальмологии

Анализ и размер европейского рынка офтальмологии

Одним из основных факторов, способствующих росту рынка офтальмологии, является растущая распространенность офтальмологических расстройств и глазных болей. Продолжающиеся клинические исследования, проводимые несколькими фармацевтическими компаниями для улучшения выбора лечения, а также воздействие определенных токсинов или изменений окружающей среды увеличивают появление офтальмологических продуктов и приводят к расширению рынка. На рынок также влияют возросший негигиеничный и малоподвижный образ жизни и рост травматических повреждений. Однако высокая стоимость и риски, связанные с хирургией и лечением глаза, отсутствие медицинской страховки у населения, особенно в развивающихся странах, и длительный период производства и разработки офтальмологических препаратов выступают в качестве сдерживающего фактора для европейского рынка офтальмологии в прогнозируемый период.

Европейский рынок офтальмологии

Европейский рынок офтальмологии

Ожидается, что рынок офтальмологии в Европе будет расти в прогнозируемый период с 2023 по 2030 год. По данным Data Bridge Market Research, среднегодовой темп роста рынка составит 5,8% в прогнозируемый период с 2023 по 2030 год, и ожидается, что к 2030 году его объем достигнет 23 186,51 млн долларов США по сравнению с 14 789,41 млн долларов США в 2022 году.

Отчет Метрика

Подробности

Прогнозируемый период

2023-2030

Базовый год

2022

Исторические годы

2021 (Возможно изменение на 2015-2020)

Количественные единицы

Доход в млн. долл. США

Охваченные сегменты

По типу продукта (устройство, лекарства и другие), заболеваниям ( глаукома , катаракта, возрастная макулярная дегенерация, воспалительные заболевания, нарушения рефракции и другие), режиму отпуска по рецепту (дженерики и брендовые), типу препарата (рецептурные и безрецептурные (OTC)), способу применения (перорально, местно, инъекционные, местные глазные и другие), конечному пользователю (больницы, клиники, домашняя медицинская помощь и другие), каналу сбыта (прямые торги, розничные продажи и другие)

Страны, охваченные

Россия, Испания, Турция, Германия, Италия, Великобритания, Франция, Венгрия, Австрия, Швейцария, Нидерланды, Польша, Ирландия, Норвегия, Литва, Остальная Европа

Охваченные участники рынка

Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., Pfizer Inc. и Ziemer Ophthalmic Systems AG и другие.

Определение рынка

Офтальмология — раздел медицины, изучающий анатомию, физиологию, лечение и хирургию зрительных путей глаза, включая окружающие области и зрительные аспекты мозга. Офтальмологические устройства — это медицинское оборудование, предназначенное для хирургии, диагностики и коррекции зрения. Устройства приобрели повышенное значение и распространение из-за высокой распространенности нескольких офтальмологических заболеваний, таких как глаукома, катаракта и других проблем со зрением. Офтальмологические препараты — это лекарства, специально разработанные и применяемые для лечения различных заболеваний глаз, включая дальтонизм, диабетический макулярный отек , цитомегаловирус (ЦМВ) и возрастную макулярную дегенерацию (ВМД). 

Динамика рынка офтальмологии

В этом разделе рассматривается понимание движущих сил рынка, преимуществ, возможностей, ограничений и проблем. Все это подробно обсуждается ниже:

Драйверы

  • Рост распространенности офтальмологических заболеваний и глазных болей

Офтальмологические расстройства являются основной причиной серьезных глазных и орбитальных болей в глазах. Глазная боль возникает на поверхности глаз вместе с такими симптомами, как царапание, жжение или зуд. Это может быть вызвано несколькими причинами, включая раздражение инородными телами, инфекцией или травмой. Ресницы или частички грязи, дым, пыль или некоторые агрессивные косметические средства для глаз являются распространенными причинами, приводящими к глазной боли, покраснению и слезотечению.

Распространенность глазной боли продолжает расти по мере роста химической промышленности и загрязнения во всем мире. Химические ожоги и ожоги от вспышки вызывают значительную и сильную глазную боль из-за раздражения поверхности глаза. Стиль и блефарит приводят к сильной глазной боли, поскольку они делают глаз и сальные железы более чувствительными в этой области. Фактор утверждения утверждает, что это является основным драйвером для европейского рынка офтальмологии.

  • Рост травматических повреждений

Травматическое повреждение головы является одной из причин таких расстройств, как расстройства зрительного нерва. Травматическое повреждение — это физическое повреждение, которое возникает внезапно с определенной степенью тяжести. Травма может быть вызвана различными внешними повреждениями. Наиболее распространенными причинами травматического повреждения являются дорожно-транспортные происшествия, спортивные травмы и насилие, среди прочего, которые также могут привести к некоторым серьезным заболеваниям глаз. Распространенность таких травматических повреждений широко распространена во всем мире.

Следовательно, такие травматические повреждения приводят к расстройствам зрительного нерва, которые поражают население в эти годы и увеличиваются с ростом населения. Поэтому ожидается, что рост травматических повреждений будет стимулировать рост рынка.

Возможности

  • Рост расходов на здравоохранение и располагаемого дохода

Расходы на здравоохранение и темпы их роста с течением времени зависят от широкого спектра экономических и социальных факторов, включая механизмы финансирования и структуру организации системы здравоохранения.

Расходы на здравоохранение увеличились во всем мире, поскольку располагаемый доход людей в разных странах увеличивается. Более того, для удовлетворения потребностей населения государственные органы и организации здравоохранения предпринимают инициативы в силу ускорения расходов на здравоохранение.

Рост расходов на здравоохранение также выгоден для дальнейшего экономического роста и роста сектора здравоохранения. Это в первую очередь плодотворно, поскольку существенно влияет на разработку более качественных и более продвинутых медицинских продуктов на рынке. Таким образом, всплеск расходов на здравоохранение может стать прекрасной возможностью для роста рынка.

  • Повышение осведомленности для предотвращения бремени глазных заболеваний

Значительные успехи в профилактике нарушений зрения были достигнуты для борьбы с видимыми заболеваниями различными организациями, такими как Всемирная организация здравоохранения (ВОЗ) и ее государства-члены, агентства ООН, неправительственные организации (НПО) и частный сектор. Поэтому второй четверг октября — Всемирный день зрения (WSD), ежегодный день осведомленности, призванный привлечь внимание Европы к слепоте и нарушениям зрения.

Таким образом, ожидается, что программы и инициативы по снижению бремени глазных заболеваний создадут возможности для роста европейского рынка офтальмологии в прогнозируемый период.

Ограничения/Проблемы

  • Высокая стоимость и риски, связанные с хирургией и лечением глаз

Стоимость лечения различных расстройств играет важную роль на рынке. Лечение расстройств зрительного нерва является весьма сложным, поскольку распространенность таких расстройств растет; следовательно, потребность в таких продуктах в конечном итоге возросла, тем самым повысив стоимость лечения, что может помешать росту рынка в ближайшие годы.

Существуют различные методы лечения расстройства неврита зрительного нерва. Некоторые из них — пациенты могут принимать различные лекарства, такие как кортикостероиды, такие как метилпреднизолон, преднизон, иммуноглобулин , инъекции витамина B12 и различные другие операции. С этим связаны некоторые риски.

Поэтому для части населения по всей стране сложно проходить такие процедуры из-за высокой стоимости. Следовательно, ожидается, что высокая стоимость лечения офтальмологических расстройств будет сдерживать рост рынка.

  • Нехватка квалифицированных специалистов

Число офтальмологов как в развивающихся, так и в промышленно развитых странах незначительно. Однако прогнозы немного выше для развивающихся стран. Число офтальмологов кумулятивно, но не так быстро, как популяция пожилых пациентов в возрасте 60 лет и старше, которым необходимо усиленное офтальмологическое обслуживание. В большинстве стран проблема заключается в том, что демографические изменения не совпадают с профессиональным развитием. Требуется обучать команды по уходу за глазами, чтобы соответствовать текущему числу офтальмологов во всем мире. Возросшая потребность в офтальмологах во всем мире также отражает рост случаев диабета. Пациенты с диабетом должны проходить осмотр глаз каждый год. Растущий спрос на офтальмологов прямо пропорционален росту гериатрического населения, поскольку уход за глазами является неотъемлемой частью здравоохранения. Пробелы в доступе к уходу можно устранить путем объединения факторов, включая более эффективные структуры практики, процессы и надлежащее использование технологий.

Влияние COVID-19 на рынок офтальмологии

Пандемия COVID-19 оказала большое влияние на офтальмологическую и хирургическую отрасли. Торговые группы в секторе офтальмологических и офтальмологических товаров утверждают, что европейская цепочка поставок операционных, диагностических и офтальмологических товаров была значительно повреждена, что повлияло на потребление офтальмологического рынка конечными пользователями. Продажи офтальмологических товаров в первом квартале 2020 года были значительно задержаны из-за логистических и транспортных проблем. Со стороны спроса рынок растет, поскольку людям приходится делать операции после сценария блокировки. Необходимо учитывать ситуацию и проводить экстренные операции. Кроме того, со стороны предложения рост рынка имеет отрицательную шкалу. Это связано с ситуациями блокировки во многих странах, производящих диагностические, операционные и офтальмологические инструменты.

Последние события

  • В октябре 2022 года компания Regeneron Pharmaceuticals, Inc. объявила, что Управление по контролю за продуктами и лекарствами США (FDA) приняло к приоритетному рассмотрению дополнительную заявку на получение лицензии на биологические препараты (sBLA) для инъекций EYLEA (aflibercept) для лечения ретинопатии недоношенных (ROP) у недоношенных детей. Это развитие помогает организации в развитии имиджа своего бренда на рынке офтальмологии, среди прочего
  • В мае 2022 года компания Reichert, Inc. запустила обновленный веб-сайт рефрактометров и аналитических приборов со значительно улучшенным пользовательским интерфейсом.

Объем рынка офтальмологии в Европе

Европейский рынок офтальмологии сегментирован по продуктам, заболеваниям, режиму рецепта, типу препарата, способу введения, конечному пользователю и каналу сбыта. Рост среди этих сегментов поможет вам проанализировать сегменты с незначительным ростом в отраслях и предоставить пользователям ценный обзор рынка и рыночные идеи для принятия стратегических решений по определению основных рыночных приложений.

Продукция

  • Устройство
  • Наркотики
  • Другие

По видам продукции рынок офтальмологии сегментируется на приборы, лекарственные препараты и т. д.

Заболевания

  • Глаукома
  • катаракта
  • Возрастная макулярная дегенерация
  • Воспалительные заболевания
  • Нарушения рефракции
  • Другие

По характеру заболеваний рынок офтальмологических услуг сегментируется на глаукому, катаракту, возрастную дегенерацию желтого пятна, воспалительные заболевания, нарушения рефракции и другие.

Режим рецепта

  • Общий
  • Фирменный

По способу выдачи рецептов рынок офтальмологических препаратов сегментируется на дженерики и брендовые препараты.

Тип препарата

  • Рецепт
  • Без рецепта (OTC)

По типу лекарственных средств рынок офтальмологических препаратов сегментируется на рецептурные и безрецептурные (OTC).

Путь введения

  • Оральный
  • Актуальный
  • Инъекционные препараты
  • Местный глазной
  • Другие

По способу применения рынок офтальмологических препаратов подразделяется на пероральные, местные, инъекционные, местные глазные и другие.

Конечный пользователь

  • Больницы
  • Клиники
  • Домашний уход за здоровьем
  • Другие

По признаку конечного потребителя рынок офтальмологии сегментируется на больницы, клиники, учреждения здравоохранения на дому и другие.

Канал распространения

  • Прямой тендер
  • Розничные продажи
  • Другие

По каналам сбыта рынок офтальмологии сегментируется на прямые торги, розничные продажи и другие.

Региональный анализ/анализ рынка офтальмологии                           

Европейский рынок офтальмологических препаратов сегментирован по видам продукции, заболеваниям, режиму назначения, типу препарата, способу введения, конечному пользователю и каналу сбыта.

Страны на европейском рынке прокладок: Германия, Италия, Великобритания, Франция, Венгрия, Австрия, Швейцария, Нидерланды, Польша, Ирландия, Норвегия, Литва и остальные страны Европы. 

Россия доминирует благодаря спросу на офтальмологическую продукцию, а также ожидается, что рост научно-исследовательских и опытно-конструкторских работ в отрасли будет способствовать развитию рынка в прогнозируемый период.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Анализ цепочек создания стоимости вверх и вниз по течению, технические тенденции, анализ пяти сил Портера и тематические исследования — вот некоторые из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность европейских брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговые пути.   

Конкурентная среда и анализ доли рынка офтальмологии в Европе

Конкурентная среда рынка офтальмологии содержит сведения о конкурентах. Включены сведения о компании, финансах компании, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, присутствии в Европе, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта и доминировании в применении. Приведенные выше данные относятся только к компаниям, сосредоточенным на европейском рынке офтальмологии.

Некоторые из основных игроков, работающих на этом рынке, включают Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., Pfizer Inc. и Ziemer Ophthalmic Systems AG, а также другие.

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 EPIDEMIOLOGY

6 STRATEGIC INITIATIVES

7 EUROPE OPHTHALMOLOGY MARKET, REGULATION

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 RISING PREVALENCE OF OPHTHALMIC DISORDERS & OCULAR PAINS

8.1.2 INCREASING UNHYGIENIC & SEDENTARY LIFESTYLE

8.1.3 RISE IN TRAUMATIC INJURIES

8.1.4 RISE IN THE GERIATRIC POPULATION

 

8.2 RESTRAINTS

8.2.1 HIGH COST & RISKS ASSOCIATED WITH EYE SURGERY & TREATMENT

8.2.2 LACK OF HEALTH INSURANCE AMONGST THE POPULATION, ESPECIALLY WITHIN THE DEVELOPING COUNTRIES

8.2.3 SIDE EFFECTS ASSOCIATED WITH TREATMENT DRUGS

8.3 OPPORTUNITIES

8.3.1 RISE IN HEALTHCARE EXPENDITURE AND DISPOSABLE INCOME

8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

8.3.3 RISING AWARENESS TO PREVENT THE BURDEN OF EYE DISEASES

8.4 CHALLENGE

8.4.1 LACK OF SKILLED PROFESSIONALS

8.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL

9 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS

9.1 OVERVIEW

9.2 DEVICE

9.2.1 SURGICAL DEVICE

9.2.1.1 CATARACT SURGICAL DEVICES

9.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

9.2.1.2.1 PHACOEMULSIFICATION DEVICES

9.2.1.2.2 CATARACT SURGICAL LASERS

9.2.1.2.3 IOL INJECTORS

9.2.1.3 VITREORETINAL SURGICAL DEVICES

9.2.1.3.1 VITREORETINAL PACKS

9.2.1.3.2 VITRECTOMY MACHINES

9.2.1.3.3 VITRECTOMY PROBES

9.2.1.3.4 PHOTOCOAGULATION LASERS

9.2.1.3.5 ILLUMINATION DEVICES

9.2.1.4 REFRACTIVE SURGICAL DEVICES

9.2.1.4.1 FEMTOSECOND LASERS

9.2.1.4.2 EXCIMER LASERS

9.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

9.2.1.5 GLAUCOMA SURGICAL DEVICES

9.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

9.2.1.5.2 GLAUCOMA LASER SYSTEMS

9.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

 

9.2.2 DIAGNOSTIC DEVICE

9.2.2.1 AUTOREFRACTORS & KERATOMETERS

9.2.2.2 TONOMETER

9.2.2.3 PHOROPTERS

9.2.2.4 RETINOSCOPES

9.2.2.5 OPHTHALMOSCOPES

9.2.2.6 PERIMETERS/VISUAL FIELD ANALYZERS

9.2.2.7 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

9.2.2.7.1 A- SCAN IMAGING SYSTEM

9.2.2.7.2 B-SCAN IMAGING SYSTEM

9.2.2.7.3 PACHYMETERS

9.2.2.7.4 ULTRASOUND BIOMICROSCOPES

9.2.2.8 LENSMETERS

9.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

9.2.2.10 OPTICAL COHERENCE TOMOGRAPHY SCANNERS

9.2.2.11 FUNDUS CAMERAS

9.2.2.12 OPTICAL BIOMETRY SYSTEMS

9.2.2.13 SPECULAR MICROSCOPES

9.2.2.14 WAVEFRONT ABERROMETERS

9.2.2.15 CHART PROJECTORS

9.2.2.16 SLIT LAMPS

9.2.3 OPHTHALMIC SURGICAL ACCESSORIES

9.2.3.1 SURGICAL INSTRUMENTS & KITS

9.2.3.2 OPHTHALMIC FORCEPS

9.2.3.3 OPHTHALMIC SPATULA

9.2.3.4 OPHTHALMIC TIPS AND HANDLES

9.2.3.5 OPHTHALMIC CANNULAS

9.2.3.6 OPHTHALMIC SCISSORS

9.2.3.7 OTHERS SURGICAL ACCESSORIES

9.2.4 OPHTHALMIC MICROSCOPES

9.3 DRUGS

9.3.1 ANTI-INFLAMMATION DRUGS

9.3.1.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

9.3.1.2 STEROIDAL ANTI-INFLAMMATORY DRUGS

9.3.2 ALLERGIC CONJUNCTIVITIS

9.3.3 DRY EYE DRUGS

9.3.4 RETINAL DISORDER DRUGS

 

9.3.5 ANTI-GLAUCOMA DRUGS

9.3.5.1 MIOTICS

9.3.5.1.1 PILOCARPINE

9.3.5.1.2 ESERINE

9.3.5.2 BETA ADRENERGIC ANTAGONISTS

9.3.5.2.1 TIMOLAL MALEATE

9.3.5.2.2 BETAXOLOL

9.3.5.3 PROSTAGLANDIN ANALOGS

9.3.5.3.1 LATANOPROST

9.3.5.3.2 BIMATOPROST

9.3.5.3.3 TRAVOPROST

9.3.5.3.4 TAFLUPROST

9.3.5.3.5 LATANOPROSTENE

9.3.5.4 ALPHA ADRENERGIC AGONISTS

9.3.5.4.1 EPINEPHRINE

9.3.5.4.2 DEPIVEPRINE

9.3.5.5 ANTI-VEGF DRUGS

9.3.5.5.1 RANIBIZUMAB

9.3.5.5.2 BEVACIZUMAB

9.3.6 OTHERS

9.4 OTHERS

9.4.1 VISION CARE PRODUCTS

9.4.1.1 SPECTACLES

9.4.1.2 CONTACT LENSES

9.4.1.2.1 SOFT CONTACT LENSES

9.4.1.2.2 HYBRID CONTACT LENSES

9.4.1.2.3 RIGID GAS PERMEABLE LENSES

9.4.2 OTHERS

10 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES

10.1 OVERVIEW

10.2 INFLAMMATORY DISEASES

10.3 CATARACT

10.4 REFRACTIVE DISORDERS

10.5 GLAUCOMA

10.6 AGE-RELATED MACULAR DEGENERATION

10.7 OTHERS

 

11 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE

11.1 OVERVIEW

11.2 BRANDED

11.3 GENERIC

12 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE

12.1 OVERVIEW

12.2 OVER THE COUNTER

12.3 PRESCRIPTION

13 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION

13.1 OVERVIEW

13.2 TOPICAL

13.2.1 EYE DROPS

13.2.2 EYE SOLUTION

13.2.3 CREAM & OINTMENTS

13.2.4 GEL

13.2.5 OTHERS

13.3 ORAL

13.3.1 TABLET

13.3.2 CAPSULES

13.3.3 OTHERS

13.4 LOCAL OCULAR

13.4.1 SUBCONJUNCTIVAL

13.4.2 INTRAVITREAL

13.4.3 RETROBULBAR

13.4.4 INTRACAMERAL

13.5 INJECTABLE

13.5.1 INTRAMUSCULAR

13.5.2 INTRAVENOUS

13.5.3 OTHERS

13.6 OTHERS

14 EUROPE OPHTHALMOLOGY MARKET, BY END USER

14.1 OVERVIEW

14.2 CLINICS

14.3 HOSPITALS

14.4 HOMECARE SETTINGS

14.5 OTHERS

 

15 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 RETAIL SALES

15.2.1 RETAIL SHOPS

15.2.2 HOSPITAL PHARMACY

15.2.3 ONLINE PHARMACY

15.3 DIRECT TENDER

15.4 OTHERS

16 EUROPE OPHTHALMOLOGY MARKET, BY GEOGRAPHY

16.1 EUROPE

16.1.1 GERMANY

16.1.2 U.K.

16.1.3 FRANCE

16.1.4 HUNGARY

16.1.5 LITHUANIA

16.1.6 AUSTRIA

16.1.7 IRELAND

16.1.8 NORWAY

16.1.9 POLAND

16.1.10 ITALY

16.1.11 SPAIN

16.1.12 RUSSIA

16.1.13 TURKEY

16.1.14 NETHERLANDS

16.1.15 SWITZERLAND

16.1.16 REST OF EUROPE

17 EUROPE OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: EUROPE

18 SWOT ANALYSIS

19 COMPANY PROFILE

19.1 ALCON

19.1.1 COMPANY SNAPSHOT

19.1.2 RECENT FINANCIALS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT DEVELOPMENTS

 

19.2 REGENERON PHARMACEUTICALS INC.

19.2.1 COMPANY SNAPSHOT

19.2.2 RECENT FINANCIALS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT DEVELOPMENT

19.3 JOHNSON & JOHNSON SERVICES, INC.

19.3.1 COMPANY SNAPSHOT

19.3.2 RECENT FINANCIALS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT DEVELOPMENT

19.4 REICHERT, INC.

19.4.1 COMPANY SNAPSHOT

19.4.2 COMPANY SHARE ANALYSIS

19.4.3 PRODUCT PORTFOLIO

19.4.4 RECENT DEVELOPMENT

19.5 NOVARTIS AG

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 COMPANY SHARE ANALYSIS

19.5.4 PRODUCT PORTFOLIO

19.5.5 RECENT DEVELOPMENTS

19.6 ABBVIE INC.

19.6.1 COMPANY SNAPSHOT

19.6.2 RECENT FINANCIALS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT DEVELOPMENT

19.7 BAUSCH & LOMB INCORPORATED

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT DEVELOPMENTS

19.8 CARL ZEISS MEDITEC AG

19.8.1 COMPANY SNAPSHOT

19.8.2 REVENUE ANALYSIS

19.8.3 PRODUCT PORTFOLIO

19.8.4 RECENT DEVELOPMENTS

 

19.9 ESSILORLUXOTTICA

19.9.1 COMPANY SNAPSHOT

19.9.2 REVENUE ANALYSIS

19.9.3 PRODUCT PORTFOLIO

19.9.4 RECENT DEVELOPMEN

19.1 F. HOFFMANN- LA ROCHE LTD

19.10.1 COMPANY SNAPSHOT

19.10.2 REVENUE ANALYSIS

19.10.3 PRODUCT PORTFOLIO

19.10.4 RECENT DEVELOPMENT

19.11 GLAUKOS

19.11.1 COMPANY SNAPSHOT

19.11.2 REVENUE ANALYSIS

19.11.3 PRODUCT PORTFOLIO

19.11.4 RECENT DEVELOPMENTS

19.12 HEIDELBERG ENGINEERING GMBH

19.12.1 COMPANY SNAPSHOT

19.12.2 PRODUCT PORTFOLIO

19.12.3 RECENT DEVELOPMENT

19.13 HOYA CORPORATION

19.13.1 COMPANY SNAPSHOT

19.13.2 REVENUE ANALYSIS

19.13.3 PRODUCT PORTFOLIO

19.13.4 RECENT DEVELOPMENTS

19.14 LUMENIS BE LTD.

19.14.1 COMPANY SNAPSHOT

19.14.2 PRODUCT PORTFOLIO

19.14.3 RECENT DEVELOPMENT

19.15 METALL ZUG AG

19.15.1 COMPANY SNAPSHOT

19.15.2 REVENUE ANALYSIS

19.15.3 PRODUCT PORTFOLIO

19.15.4 RECENT DEVELOPMENT

19.16 NEOVISION

19.16.1 COMPANY SNAPSHOT

19.16.2 PRODUCT PORTFOLIO

19.16.3 RECENT DEVELOPMENT

 

19.17 NIDEK CO., LTD.

19.17.1 COMPANY SNAPSHOT

19.17.2 PRODUCT PORTFOLIO

19.17.3 RECENT DEVELOPMENT

19.18 PFIZER INC.

19.18.1 COMPANY SNAPSHOT

19.18.2 REVENUE ANALYSIS

19.18.3 PRODUCT PORTFOLIO

19.18.4 RECENT DEVELOPMENT

19.19 SANTEN PHARMACEUTICAL CO., LTD.

19.19.1 COMPANY SNAPSHOT

19.19.2 RECENT FINANCIALS

19.19.3 PRODUCT PORTFOLIO

19.19.4 RECENT DEVELOPMENTS

19.2 SUN PHARMACEUTICAL INDUSTRIES LTD.

19.20.1 COMPANY SNAPSHOT

19.20.2 RECENT FINANCIALS

19.20.3 PRODUCT PORTFOLIO

19.20.4 RECENT DEVELOPMENTS

19.21 STAAR SURGICAL

19.21.1 COMPANY SNAPSHOT

19.21.2 REVENUE ANALYSIS

19.21.3 PRODUCT PORTFOLIO

19.21.4 RECENT DEVELOPMENTS

19.22 THE COOPER COMPANIES INC.

19.22.1 COMPANY SNAPSHOT

19.22.2 REVENUE ANALYSIS

19.22.3 PRODUCT PORTFOLIO

19.22.4 RECENT DEVELOPMENTS

19.23 TOPCON CORPORATION

19.23.1 COMPANY SNAPSHOT

19.23.2 REVENUE ANALYSIS

19.23.3 PRODUCT PORTFOLIO

19.23.4 RECENT DEVELOPMENTS

19.24 VISIONIX

19.24.1 COMPANY SNAPSHOT

19.24.2 PRODUCT PORTFOLIO

19.24.3 RECENT DEVELOPMENT

 

19.25 ZIEMER OPHTHALMIC SYSTEMS AG

19.25.1 COMPANY SNAPSHOT

19.25.2 PRODUCT PORTFOLIO

19.25.3 RECENT DEVELOPMENTS

20 QUESTIONNAIRE

21 RELATED REPORTS

Список таблиц

TABLE 1 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 2 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 4 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 5 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 6 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 7 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 8 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 9 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 10 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 11 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 12 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 14 EUROPE ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 15 EUROPE ANTI GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 16 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 17 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 18 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 19 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 20 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 21 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 23 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 24 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 25 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES 2021-2030 (USD MILLION)

TABLE 26 EUROPE INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 EUROPE CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 EUROPE REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 EUROPE GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 EUROPE AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 33 EUROPE BRANDED IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 EUROPE GENERIC IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE 2021-2030 (USD MILLION)

TABLE 36 EUROPE OVER THE COUNTER IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 EUROPE PRESCRIPTION IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 39 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 41 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 43 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 45 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 47 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 49 EUROPE CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 EUROPE HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 EUROPE HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 54 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL 2021-2030 (USD MILLION)

TABLE 56 EUROPE DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 EUROPE OPHTHALMOLOGY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 59 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 60 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 61 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 62 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 63 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 64 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 65 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 66 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 67 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 68 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 69 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 70 EUROPE ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 71 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 72 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 73 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 74 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 75 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 76 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 77 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 78 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 79 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 80 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 81 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 82 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 83 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 84 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 85 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 86 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 87 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 88 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 89 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 90 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 91 GERMANY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 92 GERMANY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 93 GERMANY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 94 GERMANY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 95 GERMANY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 96 GERMANY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 97 GERMANY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 98 GERMANY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 99 GERMANY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 100 GERMANY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 101 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 102 GERMANY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 103 GERMANY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 104 GERMANY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 105 GERMANY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 106 GERMANY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 107 GERMANY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 108 GERMANY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 109 GERMANY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 110 GERMANY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 111 GERMANY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 112 GERMANY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 113 GERMANY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 114 GERMANY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 115 GERMANY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 116 GERMANY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 117 GERMANY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 118 GERMANY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 119 GERMANY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 120 GERMANY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 121 GERMANY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 122 GERMANY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 123 U.K. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 124 U.K. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 125 U.K. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 126 U.K. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 127 U.K. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 128 U.K. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 129 U.K. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 130 U.K. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 131 U.K. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 132 U.K. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 133 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 134 U.K. ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 135 U.K. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 136 U.K. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 137 U.K. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 138 U.K. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 139 U.K. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 140 U.K. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 141 U.K. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 142 U.K. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 143 U.K. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 144 U.K. OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 145 U.K. OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 146 U.K. OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 147 U.K. OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 148 U.K. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 149 U.K. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 150 U.K. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 151 U.K. INJECTABLE IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 152 U.K. OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 153 U.K. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 154 U.K. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 155 FRANCE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 156 FRANCE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 157 FRANCE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 158 FRANCE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 159 FRANCE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 160 FRANCE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 161 FRANCE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 162 FRANCE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 163 FRANCE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 164 FRANCE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 165 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 166 FRANCE ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 167 FRANCE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 168 FRANCE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 169 FRANCE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 170 FRANCE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 171 FRANCE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 172 FRANCE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 173 FRANCE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 174 FRANCE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 175 FRANCE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 176 FRANCE OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 177 FRANCE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 178 FRANCE OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 179 FRANCE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 FRANCE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 181 FRANCE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 182 FRANCE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 183 FRANCE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 184 FRANCE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 185 FRANCE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 186 FRANCE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 187 HUNGARY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 188 HUNGARY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 189 HUNGARY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 190 HUNGARY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 191 HUNGARY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 192 HUNGARY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 193 HUNGARY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 194 HUNGARY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 195 HUNGARY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 196 HUNGARY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 197 HUNGARY DRUG IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 198 HUNGARY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 199 HUNGARY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 200 HUNGARY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 201 HUNGARY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 202 HUNGARY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 203 HUNGARY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 204 HUNGARY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 205 HUNGARY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 206 HUNGARY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 207 HUNGARY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 208 HUNGARY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 209 HUNGARY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 210 HUNGARY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 211 HUNGARY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 212 HUNGARY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 213 HUNGARY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 214 HUNGARY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 215 HUNGARY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 216 HUNGARY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 217 HUNGARY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 HUNGARY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 219 LITHUANIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 220 LITHUANIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 221 LITHUANIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 222 LITHUANIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 223 LITHUANIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 224 LITHUANIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 225 LITHUANIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 226 LITHUANIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 227 LITHUANIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 228 LITHUANIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 229 LITHUANIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 230 LITHUANIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 231 LITHUANIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 232 LITHUANIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 233 LITHUANIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 234 LITHUANIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 235 LITHUANIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 236 LITHUANIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 237 LITHUANIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 238 LITHUANIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 239 LITHUANIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 240 LITHUANIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 241 LITHUANIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 242 LITHUANIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 243 LITHUANIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 244 LITHUANIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 245 LITHUANIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 246 LITHUANIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 247 LITHUANIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 248 LITHUANIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 249 LITHUANIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 250 LITHUANIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 251 AUSTRIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 252 AUSTRIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 253 AUSTRIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 254 AUSTRIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 255 AUSTRIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 256 AUSTRIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 257 AUSTRIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 258 AUSTRIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 259 AUSTRIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 260 AUSTRIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 261 AUSTRIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 262 AUSTRIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 263 AUSTRIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 264 AUSTRIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 265 AUSTRIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 266 AUSTRIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 267 AUSTRIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 268 AUSTRIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 269 AUSTRIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 270 AUSTRIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 271 AUSTRIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 272 AUSTRIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 273 AUSTRIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 274 AUSTRIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 275 AUSTRIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 276 AUSTRIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 277 AUSTRIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 278 AUSTRIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 279 AUSTRIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 280 AUSTRIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 281 AUSTRIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 282 AUSTRIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 283 IRELAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 284 IRELAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 285 IRELAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 286 IRELAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 287 IRELAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 288 IRELAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 289 IRELAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 290 IRELAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 291 IRELAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 292 IRELAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 293 IRELAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 294 IRELAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 295 IRELAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 296 IRELAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 297 IRELAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 298 IRELAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 299 IRELAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 300 IRELAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 301 IRELAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 302 IRELAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 303 IRELAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 304 IRELAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 305 IRELAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 306 IRELAND OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 307 IRELAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 308 IRELAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 309 IRELAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 310 IRELAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 311 IRELAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 312 IRELAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 313 IRELAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 314 IRELAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 315 NORWAY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 316 NORWAY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 317 NORWAY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 318 NORWAY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 319 NORWAY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 320 NORWAY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 321 NORWAY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 322 NORWAY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 323 NORWAY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 324 NORWAY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 325 NORWAY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 326 NORWAY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 327 NORWAY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 328 NORWAY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 329 NORWAY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 330 NORWAY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 331 NORWAY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 332 NORWAY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 333 NORWAY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 334 NORWAY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 335 NORWAY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 336 NORWAY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 337 NORWAY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 338 NORWAY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 339 NORWAY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 340 NORWAY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 341 NORWAY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 342 NORWAY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 343 NORWAY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 344 NORWAY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 345 NORWAY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 346 NORWAY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 347 POLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 348 POLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 349 POLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 350 POLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 351 POLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 352 POLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 353 POLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 354 POLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 355 POLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 356 POLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 357 POLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 358 POLAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 359 POLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 360 POLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 361 POLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 362 POLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 363 POLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 364 POLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 365 POLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 366 POLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 367 POLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 368 POLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 369 POLAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 370 POLAND OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 371 POLAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 372 POLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 373 POLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 374 POLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 375 POLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 376 POLAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 377 POLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 378 POLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 379 ITALY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 380 ITALY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 381 ITALY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 382 ITALY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 383 ITALY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 384 ITALY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 385 ITALY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 386 ITALY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 387 ITALY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 388 ITALY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 389 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 390 ITALY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 391 ITALY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 392 ITALY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 393 ITALY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 394 ITALY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 395 ITALY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 396 ITALY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 397 ITALY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 398 ITALY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 399 ITALY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 400 ITALY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 401 ITALY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 402 ITALY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 403 ITALY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 404 ITALY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 405 ITALY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 406 ITALY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 407 ITALY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 408 ITALY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 409 ITALY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 410 ITALY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 411 SPAIN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 412 SPAIN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 413 SPAIN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 414 SPAIN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 415 SPAIN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 416 SPAIN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 417 SPAIN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 418 SPAIN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 419 SPAIN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 420 SPAIN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 421 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 422 SPAIN ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 423 SPAIN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 424 SPAIN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 425 SPAIN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 426 SPAIN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 427 SPAIN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 428 SPAIN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 429 SPAIN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 430 SPAIN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 431 SPAIN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 432 SPAIN OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 433 SPAIN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 434 SPAIN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 435 SPAIN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 436 SPAIN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 437 SPAIN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 438 SPAIN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 439 SPAIN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 440 SPAIN OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 441 SPAIN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 442 SPAIN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 443 RUSSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 444 RUSSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 445 RUSSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 446 RUSSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 447 RUSSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 448 RUSSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 449 RUSSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 450 RUSSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 451 RUSSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 452 RUSSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 453 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 454 RUSSIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 455 RUSSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 456 RUSSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 457 RUSSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 458 RUSSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 459 RUSSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 460 RUSSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 461 RUSSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 462 RUSSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 463 RUSSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 464 RUSSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 465 RUSSIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 466 RUSSIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 467 RUSSIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 468 RUSSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 469 RUSSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 470 RUSSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 471 RUSSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 472 RUSSIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 473 RUSSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 474 RUSSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 475 TURKEY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 476 TURKEY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 477 TURKEY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 478 TURKEY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 479 TURKEY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 480 TURKEY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 481 TURKEY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 482 TURKEY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 483 TURKEY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 484 TURKEY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 485 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 486 TURKEY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 487 TURKEY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 488 TURKEY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 489 TURKEY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 490 TURKEY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 491 TURKEY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 492 TURKEY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 493 TURKEY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 494 TURKEY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 495 TURKEY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 496 TURKEY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 497 TURKEY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 498 TURKEY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 499 TURKEY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 500 TURKEY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 501 TURKEY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 502 TURKEY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 503 TURKEY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 504 TURKEY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 505 TURKEY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 506 TURKEY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 507 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 508 NETHERLANDS DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 509 NETHERLANDS SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 510 NETHERLANDS OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 511 NETHERLANDS VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 512 NETHERLANDS REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 513 NETHERLANDS GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 514 NETHERLANDS DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 515 NETHERLANDS OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 516 NETHERLANDS OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 517 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 518 NETHERLANDS ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 519 NETHERLANDS ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 520 NETHERLANDS MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 521 NETHERLANDS BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 522 NETHERLANDS PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 523 NETHERLANDS ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 524 NETHERLANDS ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 525 NETHERLANDS OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 526 NETHERLANDS VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 527 NETHERLANDS CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 528 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 529 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 530 NETHERLANDS OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 531 NETHERLANDS OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 532 NETHERLANDS TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 533 NETHERLANDS ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 534 NETHERLANDS LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 535 NETHERLANDS INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 536 NETHERLANDS OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 537 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 538 NETHERLANDS RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 539 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 540 SWITZERLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 541 SWITZERLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 542 SWITZERLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 543 SWITZERLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 544 SWITZERLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 545 SWITZERLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 546 SWITZERLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 547 SWITZERLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 548 SWITZERLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 549 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 550 SWITZERLAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 551 SWITZERLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 552 SWITZERLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 553 SWITZERLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 554 SWITZERLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 555 SWITZERLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 556 SWITZERLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 557 SWITZERLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 558 SWITZERLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 559 SWITZERLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 560 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 561 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 562 SWITZERLAND OPHTHALMOLOGY MARKET, BY DRUG TYPE 2021-2030 (USD MILLION)

TABLE 563 SWITZERLAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 564 SWITZERLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 565 SWITZERLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 566 SWITZERLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 567 SWITZERLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 568 SWITZERLAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 569 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 570 SWITZERLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 571 REST OF EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

Список рисунков

FIGURE 1 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 EUROPE OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 EUROPE OPHTHALMOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE OPHTHALMOLOGY MARKET: DBMR POSITION GRID

FIGURE 8 EUROPE OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE OPHTHALMOLOGY MARKET: END USER COVERAGE GRID

FIGURE 10 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF OPHTHALMIC DISORDERS& INCREASING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE OPHTHALMOLOGY MARKET FROM 2022 TO 2029

FIGURE 12 THE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE OPHTHALMOLOGY MARKET FROM 2022 TO 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE OPHTHALMOLOGY MARKET

FIGURE 14 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2022

FIGURE 15 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2023-2030 (USD MILLION)

FIGURE 16 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2023-2030)

FIGURE 17 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 18 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2022

FIGURE 19 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2023-2030 (USD MILLION)

FIGURE 20 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2023-2030)

FIGURE 21 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 22 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE ,2022

FIGURE 23 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, 2023-2030 (USD MILLION)

FIGURE 24 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, CAGR (2023-2030)

FIGURE 25 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 26 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE ,2022

FIGURE 27 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, 2023-2030 (USD MILLION)

FIGURE 28 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, CAGR (2023-2030)

FIGURE 29 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 30 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 31 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 32 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 33 EUROPE OPHTHALMOLOGY MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 34 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2022

FIGURE 35 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 36 EUROPE OPHTHALMOLOGY MARKET: BY END USER, CAGR (2023-2030)

FIGURE 37 EUROPE OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 38 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 39 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 40 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 41 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 EUROPE OPHTHALMOLOGY MARKET: SNAPSHOT (2022)

FIGURE 43 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2022)

FIGURE 44 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2023 & 2030)

FIGURE 45 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2022 & 2030)

FIGURE 46 EUROPE OPHTHALMOLOGY MARKET: PRODUCTS (2023-2030)

FIGURE 47 EUROPE OPHTHALMOLOGY MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

The Europe ophthalmology market size will be worth USD 23,186.51 million by 2030.
The growth rate of the Europe ophthalmology market is 5.8% in the forecast by 2030.
The major companies in the Europe ophthalmology market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., etc.
Products, disease, prescription mode, drug type, route of administration, end-user, and distribution channel are the factors on which the Europe ophthalmology market research is based.
The rising prevalence of ophthalmic disorders & ocular pains & Rise in traumatic injuries are the growth drivers of the Europe ophthalmology market.

Просмотр связанных страниц

Banner